Inverventional Cardiology

Current Cardiology Reports

, 9:406

First online:

The risk of drug-eluting stent thrombosis with noncardiac surgery

  • Emmanouil S. BrilakisAffiliated withDallas VA Medical Center (111A) Email author 
  • , Subhash Banerjee
  • , Peter B. Berger

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Patients in whom any kind of stent, particularly a drug-eluting stent (DES), was recently implanted are at risk for stent thrombosis when they undergo noncardiac surgery, even months or years after their implantation. The risk of DES thrombosis is likely decreased by delaying noncardiac surgery for as long as possible and continuing dual or at least single antiplatelet therapy in the perioperative period. Preoperative identification and close monitoring of patients with DES may allow prevention and prompt detection and treatment of this catastrophic complication.